Efficacy and Safety clinical trials at University of California Health

1 research study open to eligible people

PRV-3279-2a Trial in Systemic Lupus
open to eligible people ages 18-70
The PREVAIL-2 study is designed to assess the safety and potential efficacy of PRV-3279 in flare prevention in systemic lupus erythematosus (SLE) patients with active disease after amelioration induced by corticosteroid treatment.
at UCLA

Last updated: March 29, 2023